AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson’s Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting – BioSpace

AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson’s Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting – BioSpace
AbbVie to Present New and Updated Data of Investigational Medicines for Parkinson's Disease and Multiple Sclerosis at 2019 American Academy of Neurology Annual Meeting  BioSpacePublished: Apr 30, 2019. Presentations include updates on ABBV-951, a subcutaneous infusion therapy for Parkinson's disease (PD), and elezanumab, ... read more
Source: Google NewsPublished on 2019-04-30